Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry (SALICOV)
Validation Diagnostique de la détection Rapide du Virus SARS-CoV-2 Dans Des échantillons Salivaires Par spectrométrie de Masse
Sponsor: Centre Hospitalier Universitaire de Nīmes
This observational or N/A phase trial investigates Covid19 and is currently completed. Centre Hospitalier Universitaire de Nīmes leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2023 — Jan 2024 [monthly]
Active Not Recruiting
-
Jul 2022 — Mar 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Feb 2022 — Jul 2022 [monthly]
Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
- Technological Innovations for Detection and Diagnosis Laboratory
For direct contact, visit the study record on ClinicalTrials.gov .